APR 22, 2021 1:24 PM PDT

mRNA Covid Vaccines May Protect Against New Strains and Common Cold

WRITTEN BY: Annie Lennon

Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work with the original strain of SARS-CoV-2, but also new variants, as well as the common cold. 

After receiving either vaccine the immune system produces CD4+ T lymphocytes, immune cells also known as helper T cells. These cells activate another type of immune cell known as B lymphocytes (B cells) which respond to surface proteins on cells infected by viruses including SARS-CoV-2. Once activated in this way, immature B cells either become plasma cells that produce antibodies that mark infected cells for disposal, or ‘memory cells’ that help the body recognize and react to the same antigens more quickly in future infections. 

For the study, the researchers examined blood samples from 30 healthy healthcare workers and lab donors who had not previously tested positive for COVID-19 before and after receiving a COVID-19 mRNA vaccine. They then withdrew CD4+ T cells from their blood samples and tested their response to protein fragments from the original SARS-CoV-2 spike protein as well as three common cold coronaviruses. 

In doing so, they identified 23 distinct T cell-targeted peptides. From these, only four were affected by the mutations seen in COVID variants from the United Kingdom and South Africa. As the other 19 peptides which are targeted by the vaccines are the same in both the original virus and the newer strains, the mRNA vaccines should theoretically induce T cells that respond to these variants too. 

The researchers say this means that the T cells induced by mRNA vaccines may prevent the variant viruses from causing severe cases of COVID-19 disease, even if they don’t prevent infection. They also noted that the vaccines led to a three-fold increase in CD4+ T cell responses to HCoV-NL63 spike peptides after vaccination, meaning that the vaccine should also work for a variant of the common cold. 

 

Sources: Medical XpressThe Journal of Clinical Investigation

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
FEB 24, 2021
Drug Discovery & Development
Novel Neurofeedback Technique Improves Symptoms of Depression and Psychosis
FEB 24, 2021
Novel Neurofeedback Technique Improves Symptoms of Depression and Psychosis
Researchers from the University of Rochester have found that real-time functional magnetic resonance imaging (fMRI) neur ...
MAR 06, 2021
Genetics & Genomics
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
MAR 06, 2021
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
Individuals with Down syndrome often have certain facial features. New research has suggested that green tea supplements ...
MAR 20, 2021
Drug Discovery & Development
Weekly Insulin for Type 2 Diabetes Proved Effective
MAR 20, 2021
Weekly Insulin for Type 2 Diabetes Proved Effective
A study found that a new once-weekly basal insulin injection holds similar efficacy, safety and lower rate of low blood ...
MAR 24, 2021
Drug Discovery & Development
Three Compounds May Be Suitable for SARS-CoV-2
MAR 24, 2021
Three Compounds May Be Suitable for SARS-CoV-2
Researchers have found that that three common antiviral and antimalarial therapeutics may be effective in vitro at targe ...
APR 01, 2021
Drug Discovery & Development
Injection Treats Childhood Blindness
APR 01, 2021
Injection Treats Childhood Blindness
A patient with a genetic-based childhood blindness has gained vision after receiving an experimental RNA therapeutic tre ...
APR 05, 2021
Neuroscience
Could a Keto Diet Treat Alzheimer's Disease?
APR 05, 2021
Could a Keto Diet Treat Alzheimer's Disease?
  Researchers from Brigham Young University have found evidence that eating a ketogenic diet- which is a diet that ...
Loading Comments...